NCT02815657 - The Drug-drug Interaction of SP2086 and Valsartan | Biotech Hunter

Enrollment

16

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Type 2 Diabetes

Interventions

DRUG

SP2086

The A sequence was that Valsartan was taken at 160mg qd on Days1-Day12; SP2086 will be administered orally (by mouth) as 200mg on Days 8-Day12.The B sequence was that SP2086 was taken at 200mg qd dose on Days 8-Day12

DRUG

Valsartan

The A sequence was that Valsartan was taken at 160mg qd on Days1-Day12; SP2086 will be administered orally (by mouth) as 200mg on Days 8-Day12.The B sequence was that SP2086 was taken at 200mg qd dose on Days 8-Day12

Trial Locations (1)

Unknown

People's Liberation Army General Hospital of Chengdu Military Region, Chengdu